MedTrace Logo

CT Scan Guide Percutaneous Biopsy of Lytic Bone Metastases of Lung Cancer : Contribution in Pathology Diagnosis and Molecular Biology

NCT03386916 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2017-12-29

No results posted yet for this study

Summary

In case of primary lung cancer, bone metastases biopsy can be done in initial diagnosis or follow-up.

Nevertheless, any study focus on rentability and biopsy complications of lytic bone lesion for the context of lung cancer.

This study aims to demonstrate that CT scan guide percutaneous biopsy of lytic bone lesion help to anatomopathologic diagnosis and molecular biology with a low complication rate inasmuch a lung cancer is suspected.

This study is observational, retrospective, one center

Conditions

  • Image-Guided Biopsy - Carcinoma, Bronchogenic / Diagnosis- Outpatients

Interventions

PROCEDURE

CT scan guide percutaneous biopsy of lytic bone metastases of lung cancer

Sponsors & Collaborators

  • University Hospital, Grenoble

    lead OTHER

Principal Investigators

  • Gilbert FERRETTI · UniversityHospital Grenoble

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-01-31
Primary Completion
2017-06-30
Completion
2018-09-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03386916 on ClinicalTrials.gov